At a glance
- Originator Ajinomoto
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action DNA synthesis inhibitors; Virus replication inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Herpes simplex virus infections